IQV — IQVIA HOLDINGS INC.
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1478242 ·
Last close
$208.05
Market Cap
$34.72B
52W High
$217.05
52W Low
$154.50
ADV30
1,420,620
Next earnings
2026-07-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 4,151,000,000 | 1,355,000,000 | 565,000,000 | 274,000,000 | 29,675,000,000 | 1,947,000,000 | 23,326,000,000 |
| Dec 2025 | 4,364,000,000 | 1,436,000,000 | 651,000,000 | 514,000,000 | 29,944,000,000 | 1,980,000,000 | 23,314,000,000 |
| Sep 2025 | 4,100,000,000 | 1,373,000,000 | 573,000,000 | 331,000,000 | 28,727,000,000 | 1,814,000,000 | 22,439,000,000 |
| Jun 2025 | 4,017,000,000 | 1,323,000,000 | 538,000,000 | 266,000,000 | 28,632,000,000 | 2,039,000,000 | 22,846,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,704,000,000
Investing CF
$-2,196,000,000
Financing CF
$-325,000,000
CapEx
$-588,000,000
Dividends Paid
—
Buybacks
$-1,421,000,000
EPS Diluted TTM
$8.07
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$7,699,000,000
Inventory
—
Receivables
$3,375,000,000
ST Investments
$156,000,000
EBIT TTM
$2,352,000,000
Pretax Income TTM
$1,596,000,000
Interest Exp TTM
$756,000,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$16,632,000,512
EBITDA
$3,000,999,936
Free Cash Flow
$2,276,750,080
Enterprise Value
$48,723,709,952
Total Cash
$2,103,000,064
Total Debt
$16,097,000,448
Shares Out
166,900,000
Trailing EPS
$8.04
Book Value
$37.27
ROE
22.5%
ROA
5.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,310,000,000 | 2,287,000,000 | 1,360,000,000 | 29,944,000,000 | 23,314,000,000 | — | 2,654,000,000 |
| Dec 2024 | 15,405,000,000 | 2,269,000,000 | 1,373,000,000 | 26,899,000,000 | 20,832,000,000 | — | 2,716,000,000 |
| Dec 2023 | 14,984,000,000 | 2,061,000,000 | 1,358,000,000 | 26,681,000,000 | 20,569,000,000 | — | 2,149,000,000 |
| Dec 2022 | 14,410,000,000 | 1,827,000,000 | 1,091,000,000 | 25,337,000,000 | 19,572,000,000 | — | 2,260,000,000 |
TTM Snapshot
Revenues TTM
$14,503,000,000
NetIncome TTM
$1,210,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,899,000,000
Forward EPS
$14.17
Max Pain — expiry 2026-08-21
max pain strike: $195.00 · spot: $208.05 · call oi: 3,393 · put oi: 4,760
Expected Move to 2026-08-21:
±$22.05
(10.60%) —
implied range
$186.00 –
$230.10
· ATM straddle on $210.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $42.94B | $544.32 | — |
| INCY | INCYTE CORP | $23.51B | $117.67 | — |
| MEDP | Medpace Holdings, Inc. | $16.78B | $601.38 | — |
| ICLR | ICON PLC | $12.79B | $165.76 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $10.91B | $226.58 | — |
News headlines (Yahoo Finance, 1h cache)
IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?
2026-07-24 16:54 · Yahoo
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline
2026-07-23 14:00 · Yahoo
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
2026-07-21 14:00 · Yahoo
IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States
2026-07-16 17:39 · Yahoo
IQV vs. PEN: Which Stock Is the Better Value Option?
2026-07-14 15:40 · Yahoo
1 Cash-Producing Stock to Target This Week and 2 We Question
2026-07-10 07:43 · Yahoo
IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience
2026-07-09 16:11 · Yahoo
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026
2026-07-08 20:15 · Yahoo
ICON Stock and the CRO Trends Shaping Its Next Growth Phase
2026-07-08 18:09 · Yahoo
Is IQVIA Holdings (IQV) Resilient to AI Concerns?
2026-07-08 11:29 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.